Sales and Marketing

Showing 15 posts of 11526 posts found.

European flag

Changes to patient information in Europe

February 23, 2012 Medical Communications, Sales and Marketing Commission, EC, ED, parliament

European authorities have made new proposals to allow pharma to communicate with patients and the public  – but a ban …
FDA picture

Obesity drug supported by FDA panel

February 23, 2012 Sales and Marketing FDA, Qnexa, Vivus, Xenical, obesity

Vivus’ obesity drug Qnexa has been supported by an FDA panel, two years after it was knocked back by the …
EMA image

EMA to open up drug evaluation process

February 22, 2012 Medical Communications, Sales and Marketing CHMP, EMA, FDA

The European Medicines Agency will publish ongoing drug evaluations in an effort to make its processes more transparent. The Agency …

Alex Gorsky named new chief executive of J&J

February 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alex Gorsky, J&J, JJ, Janssen, Weldon

Johnson & Johnson has named Alex Gorsky as its new chief executive, effective from 26 April. Gorsky was also nominated …
Caprelsa image

Caprelsa approved in Europe for thyroid cancer

February 21, 2012 Sales and Marketing AstraZeneca, Caprelsa, FDA, RET, thyroid cancer

The European Commission has approved AstraZeneca’s thyroid cancer pill Caprelsa. Caprelsa (vandetanib) is now available in Europe for the treatment …
Zytiga image

Zytiga approved in Wales – for now

February 21, 2012 Sales and Marketing AWMSG, CDF, Janssen, NICE, Wales, Zytiga

Janssen’s cancer treatment Zytiga has been approved in Wales, in contrast to its rejection by NICE. The All Wales Medicines …
Georg Toufar

Working Life: Georg Toufar, director, Mundipharma

February 21, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Georg Toufar, Mundipharma, Working Life

Georg Toufar is director of European marketing and sales and member of the executive committee at Mundipharma International Limited (MINT).  …

Bayer eye drug succeeds in long-term study

February 21, 2012 Research and Development, Sales and Marketing Bayer, Lucentis, aflibercept, wet AMD

Bayer’s eye drug aflibercept has succeeded in a long-term study in patients with a common eye condition.  The Phase III …

Setback for Gilead hep C candidate

February 20, 2012 Research and Development, Sales and Marketing ELECTRON, GS-7977, Gilead, Pharmasset

Gilead’s investigational hepatitis C drug has been dealt a blow after patients suffer relapses in a mid-stage trial.  In the …

Pfizer closes in on $545m China generics deal

February 20, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing China, Hisun, Pfizer, Zhejiang, generics

Pfizer has moved a step closer to a deal with Shanghai-based Zhejiang Hisun Pharmaceutical to develop generic drugs in China.  …

Health Information appoints Nigel Brooksby as its deputy chairman

February 20, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Brooksby, Health Information

Health Information, a provider of medicine adherence services in the UK, has appointed former ABPI president Nigel Brooksby as its …
Zelboraf image

European approval for Roche’s Zelboraf

February 20, 2012 Sales and Marketing Cancer, Roche, Yervoy, Zelboraf, melanoma

Roche’s skin cancer pill Zelboraf has been given European approval to treat advanced melanoma.  Zelboraf (vemurafenib) is now available in …
Tyverb picture

GSK pulls Tyverb extension in Europe

February 17, 2012 Sales and Marketing GSK, Herceptin, Tyverb, Xeloda

GlaxoSmithKline has withdrawn its European application to extend the licence of its breast cancer pill Tyverb. The firm was seeking …
Tarceva image

NICE no for first line Tarceva

February 17, 2012 Sales and Marketing CDF, Cancer, NICE, Roche, Tarceva

NICE no for first line Tarceva Watchdog wants more information on Roche’s drug NICE is not recommending Roche’s lung cancer …
Merck image

Merck unveils Brazilian joint venture

February 17, 2012 Sales and Marketing Brazil, Merck & Co, Supera Farma, emerging markets

Merck Inc has bolstered its presence in emerging markets by entering a joint venture with Brazilian firm Supera Farma Laboratorios. Due …
The Gateway to Local Adoption Series

Latest content